via Nano Magazine
HZDR researchers trace cancer cells with tailor-made materials
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and FU Berlin has made important progress in this area: the scientists have produced tiny nanoparticles that are designed to specifically target cancer cells. They can navigate directly to the tumor cells and visualize those using advanced imaging techniques. Both in petri dishes and animal models, the scientists were able to effectively guide the nanoparticles to the cancer cells. The next step is to combine the new technique with therapeutic approaches.
The HZDR researchers start out with tiny, biocompatible nanoparticles made of so-called dendritic polyglycerols that serve as carrier molecules. “We can modify these particles and introduce various functions,” explains Dr. Kristof Zarschler, research associate at HZDR’s Institute of Radiopharmaceutical Cancer Research. “For example, we can attach an antibody fragment to the particle that specifically binds to cancer cells. This antibody fragment is our targeting moiety that directs the nanoparticle to the tumor.”
The target of the modified nanoparticles is an antigen known as EGFR (epidermal growth factor receptor). In certain types of cancer, such as breast cancer or head and neck tumors, this protein is overexpressed on the surface of the cells. “We were able to show that our designed nanoparticles preferentially interact with the cancer cells via these receptors,” confirms Dr. Holger Stephan, leader of the Nanoscalic Systems Group at HZDR. “In control tests with similar nanoparticles that had been modified with an unspecific antibody, significantly fewer nanoparticles accumulated at the tumor cells.”
The scientists intensively studied the nanoparticles’ behavior both in cell cultures and in an animal model. For this purpose, they provided the nanoparticles with additional reporter characteristics, as Kristof Zarschler explains: “We used two complementary possibilities. In addition to the antibodies, we attached dye molecules and radionuclides to the nanoparticles. The dye molecule emits in the near infrared spectrum that penetrates the tissue and can be visualized with an appropriate microscope. The dye thus reveals where exactly the nanoparticles are located.” The radionuclide, copper-64, fulfils a similar purpose. It emits radiation that is detected by a PET scanner (positron emission tomography). The signals can then be converted into a three-dimensional image that visualizes the distribution of the nanoparticles in the organism.
Excellent properties in living organisms
Using these imaging techniques, researchers have been able to show that nanoparticle accumulation in the tumor tissue reaches maximum two days after administration to mice. The labelled nanoparticles are subsequently eliminated via the kidneys without being a burden for the body. “They are apparently ideal in size and properties,” says Holger Stephan. “Smaller particles are filtered out of the blood in just a few hours and thus only have a short-term impact. If, on the other hand, the particles are too big, they accumulate in the spleen, liver or lungs and cannot be removed from the body via the kidneys and bladder.” The interplay between the nanoparticles with an exact size of three nanometers and the attached antibody fragments evidently has a positive influence on the distribution and retention of the antibody in the organism as well as on its excretion profile.
In future experiments, the HZDR researchers want to test whether they can modify their system to carry other components. Kristof Zarschler describes the plans: “You can take these nanoparticles and functionalize them with an active substance. Then you can deliver a drug directly to the tumor. This might be a therapeutic radionuclide that destroys the tumor cells.” It is also possible to attach antibody fragments specific for proteins other than EGFR to target different types of cancer.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Chip-based digital PCR detection technology and instrument developedon August 20, 2021 at 11:34 am
They then used PCR additives and nanoparticles to make the traditional loop mediated isothermal amplification (LAMP) suitable for nanoliter-scale amplification. Results suggested that ...
- Groundbreaking visualization of atomic movementson August 18, 2021 at 5:00 pm
The new method makes it possible to identify and locate the individual atoms in the nanoparticle, even if they are vibrating and moving. A group of leading electron microscopy and catalysis ...
- Solution Synthesis of Inorganic Functional Materials - Films, Nanoparticles, and Nanocompositeson August 18, 2021 at 2:24 am
Symposium M, 'Solution Synthesis of Inorganic Functional Materials - Films, Nanoparticles, and Nanocomposites' was held April 1–5, 2013 at the 2013 MRS Spring Meeting in San Francisco, California. The ...
- CureVac and GSK COVID-19 vaccine shows promise in pre-clinical studyon August 17, 2021 at 5:27 am
CureVac and GSK's second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrated improved immune response in pre-clinical study.
- Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possibleon August 17, 2021 at 3:30 am
Without Ian MacLachlan’s innovative delivery system, Moderna and Pfizer couldn’t safely get their mRNA vaccines into your cells. So why does hardly anyone acknowledge the Canadian biochemist’s seminal ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Nanoparticles in Targeted Cancer Therapyon August 19, 2021 at 5:00 pm
Recent preclinical data highlights mesoporous silica nanoparticles (MSNs) as a safe, biocompatible technology platform for targeted drug delivery. Silica-based nanoparticles C-dots were recently ...
- What Are Nanocomposites?on August 18, 2021 at 2:29 pm
Fillers with nanoparticles have a small number of atoms per particle ... flame retardant products, biodegradable and biocompatible materials. The application areas for nanocomposites includes medical ...
- ChemoRad Nanoparticles: A Novel Multifunctional Nanoparticle Platform for Targeted Delivery of Concurrent Chemoradiationon August 17, 2021 at 5:00 pm
In this study, we report the development of a novel NP (nanoparticle) therapeutic, ChemoRad NP, which can deliver biologically targeted chemoradiation. Method: A biodegradable and biocompatible ...
- Soft implantable drug delivery device integrated wirelessly with wearable devices to treat fatal seizureson August 8, 2021 at 5:00 pm
1 Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea. 2 School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National ...
- New elastomers achieve unprecedented 5000% elongation at breakon August 1, 2021 at 5:00 pm
The silica nanoparticle-reinforced material approaches 5000% elongation ... along with a highly refined biocompatible version. Currently available elastomers typically achieve between 100 and 1000% ...